Skin and immunology
LL-37
Antimicrobial peptide studied, among other settings, in topical wound-care trials.
Search names: LL37, Cathelicidin
Evidence
Catalogue entry · see sources
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
No value has been added to this entry.
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
Adverse effects are not fully mapped in this entry. Consult the sources for the specific compound and use.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Find researchPubMed · LL-37↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.